北京同仁堂股份有限公司章程 修订对照表 为贯彻落实《中华人民共和国公司法（2023 修订）》、中国证券监督管理委员会《上市公司章程指引（2025）》、《上海证券交易所股票 上市规则》、上海证券交易所上市公司自律监管指引等要求，进一步完善和提升北京同仁堂股份有限公司（以下简称公司）治理水平，结 合公司内部控制管理实际，拟对《北京同仁堂股份有限公司章程》（以下简称《公司章程》）作出如下修订： | 序号 | 原条款 | 修订后的条款 | | --- | --- | --- | | | 第一条 为维护公司、股东和债权人的合法权益，规范公 | 第一条 为维护公司、股东、职工和债权人的合法权益，规范公司 | | | 司的组织和行为，根据《中华人民共和国公司法》（以下 | | | | 简称《公司法》）、《中华人民共和国企业国有资产法》、 | 的组织和行为，根据《中华人民共和国公司法》（以下简称《公司 | | | | 法》）、《中华人民共和国企业国有资产法》《中华人民共和国证券 | | | 《中华人民共和国证券法》（以下简称《证券法》）、《中国 | 法》（以下简称《证券法》）、《中国共产党章程》（以下简称《党 | | 1 | ...

证券代码：600085 证券简称：同仁堂 公告编号：2025-018 北京同仁堂股份有限公司 潘宝侠女士最近三年不存在受到中国证券监督管理委员会、证券交易所及其 他部门行政处罚的情形，不存在相关法律、法规和《北京同仁堂股份有限公司章 程》规定的不得担任上市公司董事、高级管理人员的情形，其任职资格符合相关 法律、法规和《北京同仁堂股份有限公司章程》等有关规定。 特此公告。 北京同仁堂股份有限公司董事会 2025 年 6 月 28 日 关于聘任高级管理人员及选举非独立董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 北京同仁堂股份有限公司（以下简称公司）于 2025 年 6 月 26 日召开第十届 董事会第十一次会议，审议通过了《关于聘任公司高级管理人员的议案》及《关 于选举公司第十届董事会非独立董事的预案》，现将有关事项公告如下： 一、 聘任公司高级管理人员 经公司第十届董事会审计委员会 2025 年第三次会议、第十届董事会提名委 员会 2025 年第二次会议、第十届董事会第十一次会议审议通过，同意聘任潘宝 侠女士（简 ...

证券代码：600085 证券简称：同仁堂 公告编号：2025-019 北京同仁堂股份有限公司董事会 2025 年 6 月 28 日 1 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 为贯彻落实《中华人民共和国公司法》、中国证券监督管理委员会（以下简 称中国证监会）《上市公司章程指引》《上海证券交易所股票上市规则》、中国证 监会《关于新<公司法>配套制度规则实施相关过渡期安排》等要求，结合北京 同仁堂股份有限公司（以下简称公司）内部控制管理实际，对《北京同仁堂股份 有限公司章程》及《北京同仁堂股份有限公司股东会议事规则》《北京同仁堂股 份有限公司董事会议事规则》（以下简称公司章程及章程附件）进行修订。 本事项已经公司第十届董事会第十一次会议审议通过，尚需提交公司股东大 会审议。修订后的公司章程及章程附件、公司章程修订对照表等文件全文同日刊 载于上海证券交易所网站（www.sse.com.cn）。 本次公司章程及章程附件修订事项完成后，公司将不再设置监事会，监事会 的职权由董事会审计委员会行使，原《北京同仁堂股份有限公司监事会议 ...

证券代码：600085 证券简称：同仁堂 公告编号：2025-020 北京同仁堂股份有限公司 关于召开2025年第二次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一) 股东大会类型和届次：2025年第二次临时股东大会 (二) 股东大会召集人：董事会 (三) 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票 相结合的方式 (四) 现场会议召开的日期、时间和地点 召开的日期时间：2025 年 7 月 14 日 9 点 30 分 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 7 月 14 日 至2025 年 7 月 14 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通过互 联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 (六) 融资融券、转融通、约定购回业务账户和沪股通投资者 ...

二、会议审议情况 (一) 审议通过了《关于聘任公司高级管理人员的议案》 同意聘任潘宝侠女士（简历附后）为公司总会计师，任期自公司董事会审议 通过之日起至第十届董事会任期届满之日止。 证券代码：600085 证券简称：同仁堂 公告编号：2025-017 北京同仁堂股份有限公司 第十届董事会第十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、会议召开情况 北京同仁堂股份有限公司（以下简称公司）第十届董事会第十一次会议于 2025 年 6 月 26 日在公司会议室以现场结合通讯会议方式召开。本次会议通知已 提前送达全体董事，与会各位董事均已知悉与本次会议所议事项的相关必要信息。 本次董事会会议应出席董事 9 人，实际出席 9 人。公司全体监事及部分高级管理 人员列席了本次会议。会议由董事长邸淑兵先生主持，会议的召开和表决程序符 合《中华人民共和国公司法》及《北京同仁堂股份有限公司章程》（以下简称《公 司章程》）的有关规定。 表决结果：同意 9 票，反对 0 票，弃权 0 票。 本事项已经公司第十届董事会审计委员 ...

Core Viewpoint - The immersive exhibition showcasing traditional Chinese craftsmanship and intangible cultural heritage at the AIIB annual meeting successfully attracted international attention and generated significant sales of cultural products. Group 1: Exhibition Overview - The AIIB's 10th Annual Meeting featured an exhibition from June 24 to 26, where 12 representative enterprises presented a diverse array of cultural products combining "intangible heritage skills, time-honored brands, and cultural IP" [2][4]. - The exhibition transformed intangible cultural heritage into tangible products such as fridge magnets, brooches, cloisonné items, tea sets, and handicrafts, making them accessible to attendees [3][5]. Group 2: International Reception - The exhibition attracted over a thousand domestic and international guests, with many foreign attendees expressing enthusiasm for traditional Chinese medicine and cultural products [3][4]. - Foreign guests actively purchased various cultural products, indicating a strong interest in experiencing and taking home elements of Chinese culture [4][9]. Group 3: Product Innovation - Companies like Yida Ge and the Cloisonné Factory showcased innovative products that blend traditional craftsmanship with modern design, such as scented candles and lifestyle products inspired by traditional ink culture [6][7]. - The collaboration between Cai Bai and cultural landmarks resulted in a jewelry series that creatively interprets royal garden architecture and cultural elements [7]. Group 4: Cultural Engagement - The exhibition emphasized interactive experiences, allowing foreign guests to engage with traditional techniques, thus breaking down cultural barriers and fostering a deeper understanding of Chinese culture [8][10]. - The focus on demand-driven cultural export rather than mere product promotion was highlighted, with an emphasis on creating meaningful connections with foreign audiences [10][11]. Group 5: Youth Engagement and Innovation - The rise of Generation Z has prompted traditional brands to adapt and innovate, making cultural heritage relevant to younger audiences through modern expressions [11][12]. - The importance of the "craftsman spirit" was emphasized, highlighting the need for patience, dedication, and respect for traditional culture in the transmission of skills to younger generations [12].

Core Insights - The "Party Building Leading Industry Innovation Joint Construction Mechanism" was officially launched, expanding from 3 to 15 member units within a year, focusing on product and service upgrades to meet evolving consumer demands [1][2] - The mechanism aims to integrate high-quality party building with high-quality enterprise development, addressing the disconnect between party building and business operations [1][2] Group 1 - The establishment of the joint construction mechanism is driven by a shared need among member units for "party building to lead innovative development" [1] - Member units have collaborated on over 60 projects with a total cooperation amount of nearly 27 million yuan, enhancing the health and elderly care industry [2] - The joint construction mechanism has successfully promoted the integration of party building and business practices, achieving significant results in both areas [2][3] Group 2 - The joint construction mechanism has facilitated the introduction of diverse health products, such as "Overnight Vitality Tea" and "Medicinal Diet Gift Boxes," which blend traditional Chinese medicine with modern health concepts [3] - Future activities will include initiatives like "Party Newspaper into Communities" and "Party Building Joint Construction into Communities, Enterprises, and Universities," aimed at delivering quality products to the public [3]

Core Viewpoint - Tong Ren Tang has demonstrated resilience and growth in a complex macroeconomic environment, achieving steady revenue growth and maintaining its position as a leading traditional Chinese medicine enterprise [2]. Financial Performance - In 2024, Tong Ren Tang achieved operating revenue of 18.597 billion yuan, representing a year-on-year increase of 4.12% [2]. - The net profit attributable to shareholders of the listed company saw a decline, but the company managed to maintain growth in operating revenue and net assets through targeted strategies [2]. - The total cash dividend proposed for 2024 is 1.371 billion yuan, accounting for 89.86% of the net profit attributable to shareholders, reflecting the company's commitment to shareholder returns [3]. Marketing and Innovation - The company has implemented marketing reforms by increasing retail outlets, integrating online and offline operations, and expanding medical terminal businesses to enhance market competitiveness [2]. - Tong Ren Tang has increased investment in technological innovation to modernize traditional Chinese medicine, laying a solid foundation for long-term development [2][4]. Governance and Communication - The company continues to improve internal management systems and emphasizes the supervisory role of independent directors to ensure scientific and standardized decision-making [3]. - Management actively engages with investors through regular performance briefings and investor communication events to build trust and confidence [3]. Future Development Strategy - Tong Ren Tang plans to focus on high-quality development in the health sector, enhancing market share and brand influence through marketing reforms and brand building [4]. - The company aims to increase research and development investments, promoting the integration of traditional Chinese medicine with modern technology [4]. - Plans include expanding overseas markets and enhancing international brand influence through partnerships with global pharmaceutical companies [4]. Social Responsibility - The company is committed to sustainable development, increasing environmental investments, and engaging in public welfare activities to support the inheritance and development of traditional Chinese medicine [5]. - Future initiatives will focus on accelerating medical industrial upgrades and digital transformation to enhance productivity [5].

证券代码：600085 证券简称：同仁堂 公告编号：2025-016 北京同仁堂股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/6/27 | － | 2025/6/30 | 2025/6/30 | 差异化分红送转： 否 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经北京同仁堂股份有限公司（以下简称公司）2025 年 6 月 16 日的2024年年度股东大会审议通过。 二、 分配方案 1. 发放年度：2024年年度 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称中国结算上海分公司）登记在册的本公司全体股东。 每股分配比例 A 股每股现金红利0.50元 相关日期 公司股东中国北京同仁堂（集团）有限责任公司的现金红利由公司自 ...

Core Viewpoint - The article highlights the successful cultural exchange and promotion of traditional Chinese medicine through the innovative branding of Beijing Tongrentang's "Shengmai Drink" at the FIBA OPEN 3x3 basketball tournament in Geneva, showcasing the integration of Eastern and Western cultures [1][9]. Group 1: Cultural Exchange and Branding - Beijing Tongrentang's "Shengmai Drink" features IP characters "Ginseng Doll" and "Dangshen Doll," which have gained significant attention and sparked discussions in Geneva, illustrating the appeal of Chinese herbal wisdom [1][3]. - The design of the IP characters combines traditional Chinese aesthetics with modern elements, attracting international audiences and facilitating cross-cultural communication [7][9]. Group 2: Health and Sports Integration - The brand promotes a health-conscious message that resonates with athletes, emphasizing the importance of health in sports performance, which aligns with the principles of traditional Chinese medicine [5][10]. - The "Shengmai Drink" embodies the concept of "benefiting qi and nourishing yin," effectively addressing the health needs of basketball players during the tournament [5][7]. Group 3: Global Expansion and Future Plans - Beijing Tongrentang has established a presence in 26 countries and regions with over 3,084 retail and medical service locations, transitioning from a local to a global brand [10]. - The company aims to continue promoting the modernization and internationalization of traditional Chinese medicine, enhancing global understanding of its cultural and health values [10].